Stay updated on Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s displayed release/version label was incremented from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T22:27:35.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No user-facing content changes are evident.
    Difference
    0.1%
    Check dated 2026-04-17T14:08:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    No substantive changes detected; the page content appears unchanged from the prior version.
    Difference
    0.1%
    Check dated 2026-04-10T09:09:28.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Updated the study record with a new results posting date (Results First Posted 2025-02-17) and related QC updates.
    Difference
    0.1%
    Check dated 2026-04-03T05:49:56.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Cosmetic/UI layout changes were observed. Core study details, enrollment numbers, and outcomes remain unchanged.
    Difference
    0.1%
    Check dated 2026-03-27T02:34:37.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    Added hepatocellular carcinoma to the study's eligible conditions and updated the page to revision v3.5.0 (replacing v3.4.3).
    Difference
    0.2%
    Check dated 2026-03-19T23:52:25.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.